
CBPE Capital announces investment in Access Infinity, enhancing market access solutions for the pharmaceutical sector. Read more about this strategic partnership.
CBPE Capital has made a significant investment in Access Infinity, a leading provider of market access, pricing, and evidence strategy solutions tailored for the pharmaceutical and biotech sectors. Founded in 2014, Access Infinity has built a reputation as a trusted partner for life sciences companies globally, offering a comprehensive suite of software and consulting services that assist clients throughout the drug development lifecycle.
The investment from CBPE is designed to bolster Access Infinity’s growth strategy, enhance its technology platform, and expand its international footprint. The company currently serves 22 of the top 25 pharmaceutical firms, underscoring its pivotal role in the industry. CBPE’s backing will enable Access Infinity to continue investing in talent, innovation, and service offerings, further solidifying its market position.
“We are delighted to partner with CBPE for the next stage of our journey. Their experience and support will be invaluable as we continue to grow our business, invest in our people, and deliver exceptional value to our clients,” said a representative from Access Infinity.
CBPE Capital, known for its strong track record in supporting high-growth businesses in healthcare and technology, expressed confidence in Access Infinity’s leadership team. “We have been hugely impressed by Access Infinity’s expertise, innovation, and client-centric approach. We are excited to be working closely with the team to help realize their exciting plans for growth and continued leadership in the market access space,” stated a CBPE spokesperson.
The deal was facilitated by a team of advisors, with CBPE receiving guidance from Simmons & Simmons (legal), LEK (commercial), PwC (Tax & Structuring), Howden (Insurance), Anthesis (ESG), and Bourne Partners (M&A). Access Infinity was advised by Clearwater (M&A), Squire Patton Boggs (legal), KPMG (financial, tax), Boston Consulting Group (commercial), and Crosslake (technology).
As Access Infinity prepares for this new chapter, the focus will be on integrating advanced analytics into its software solutions and developing new consulting services that meet evolving market needs. The partnership is expected to enhance service offerings through combined expertise and improve market access strategies by leveraging CBPE’s insights.
Looking ahead, the integration of CBPE’s resources with Access Infinity’s operations will be crucial. Challenges may arise in aligning corporate cultures and integrating technology platforms, but both companies are committed to managing these transitions effectively. The investment is anticipated to create significant value, positioning Access Infinity for continued success in a competitive landscape.